Search - tctmd.com

Displaying 161 - 180 of 189

Sort: Relevancy | Date

DOACs Not Associated With Major Bleeding, Mortality: Observational Analysis

News Daily News

DOACs Not Associated With Major Bleeding, Mortality: Observational Analysis

Michael O'Riordan

October 19, 2017

Hormone Therapy Doesn’t Impact Long-term All-Cause, CV, or Cancer Mortality: WHI Analysis

News Daily News

Hormone Therapy Doesn’t Impact Long-term All-Cause, CV, or Cancer Mortality: WHI Analysis

September 14, 2017

Prolonged Standing at Work Linked to Increased CV Risk

News Daily News

Prolonged Standing at Work Linked to Increased CV Risk

August 21, 2017

Cardiac Complications of Cancer: Arterial Thromboembolism Risk Doubles With Incident Diagnosis

News Daily News

Cardiac Complications of Cancer: Arterial Thromboembolism Risk Doubles With Incident Diagnosis

Yael L. Maxwell

August 14, 2017

Inferior Vena Cava Filter Use Fell After FDA Warning but Remains High

News Daily News

Inferior Vena Cava Filter Use Fell After FDA Warning but Remains High

July 12, 2017

News Daily News

Betrixaban Approved for Prevention of VTE

Michael O'Riordan

June 23, 2017

Younger, Heavier, and Uninsured: Trends Point to Rising Risks in Acute MI, Ischemic Stroke Patients

News Daily News

Younger, Heavier, and Uninsured: Trends Point to Rising Risks in Acute MI, Ischemic Stroke Patients

Yael L. Maxwell

April 11, 2017

Monthly Vitamin D Fails to Prevent CVD in Large Randomized Trial

News Daily News

Monthly Vitamin D Fails to Prevent CVD in Large Randomized Trial

April 07, 2017

EINSTEIN CHOICE: Rivaroxaban or Aspirin for Extended Treatment of Venous Thromboembolism

Presentation ACC 2017

EINSTEIN CHOICE: Rivaroxaban or Aspirin for Extended Treatment of Venous Thromboembolism

Presenter: Jeff Weitz

March 20, 2017

Rivaroxaban Bests Aspirin for Preventing Recurrence of VTE: EINSTEIN CHOICE

News Conference News ACC 2017

Rivaroxaban Bests Aspirin for Preventing Recurrence of VTE: EINSTEIN CHOICE

March 18, 2017

ACC 2017: CVD Outcomes for Evolocumab, Intermediate-Risk TAVR, Coronary Physiology Tests, and More

News Conference News ACC 2017

ACC 2017: CVD Outcomes for Evolocumab, Intermediate-Risk TAVR, Coronary Physiology Tests, and More

March 10, 2017

Testing Testosterone: Two Studies Show Nothing to Promote Its Use Among Cardiovascular Patients

News Daily News

Testing Testosterone: Two Studies Show Nothing to Promote Its Use Among Cardiovascular Patients

Yael L. Maxwell

February 24, 2017

News Daily News

Testosterone Therapy Raises Risk of VTE Early but Not Beyond 6 Months

Michael O'Riordan

December 01, 2016

News Conference News AHA 2016

Dabigatran Reversal Agent’s Safety, Efficacy Affirmed With Updated Study Results

November 15, 2016

News Daily News

研究人员称考虑肺栓塞为不明原因晕厥原因“很重要”

Michael O'Riordan

October 24, 2016

News Daily News

Según los Investigadores, Contemplar de Embolismo Pulmonar por Síncope Inexplicado es ‘Absolutamente Obligatorio.’

Michael O'Riordan

October 24, 2016

News Daily News

Considering Pulmonary Embolism for Unexplained Syncope Is ‘Absolutely Mandatory,’ Investigators Say

Michael O'Riordan

October 24, 2016

News Daily News

Treatment Duration May Explain Inconsistent Risks Seen With Testosterone Therapy

May 12, 2016

News Daily News

血流动力学指导的补液可减少肾病和心衰患者的造影剂肾病

December 09, 2015

News Daily News

Hemodynamic Guidance of Hydration Cuts Contrast Nephropathy in Patients With Kidney Disease, Heart Failure

December 09, 2015

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.